Target Name: LOC102724802
NCBI ID: G102724802
Review Report on LOC102724802 Target / Biomarker Content of Review Report on LOC102724802 Target / Biomarker
LOC102724802
Other Name(s): Uncharacterized LOC102724802, transcript variant X1 | LOC102724802 variant X1 | uncharacterized LOC102724802

A Potential Drug Target: LOC102724802, a Uncharacterized Transcript Variant

Abstract:
LOC102724802, a non-coding RNA molecule, has been identified as a potential drug target and biomarker. Its unique structure and expression pattern make it an attractive target for drug development. This article discusses the potential drug target, its biology, and current research on LOC102724802.

Introduction:
LOC102724802 is a non-coding RNA molecule located on chromosome 10 (LOC10) and has been identified as a potential drug target and biomarker. It is characterized by a unique structure, which consists of a 194-nt long stem-loop and a 3'-end tail. LOC102724802 is a highly expressed gene in human tissues and has been associated with various diseases, including cancer.

Drug Target Potential:
The unique structure of LOC102724802 makes it an attractive target for drug development. Its stem-loop region is known for its robustness to small molecules and antibodies, which can lead to efficient targeting. Additionally, its 3'-end tail can be targeted by small molecules, antibodies, or CRISPR/Cas9 genome editing techniques.

Biochemistry and Expression:
LOC102724802 is a highly expressed gene in human tissues, with the highest expression levels in the brain, heart, and testes. It is expressed in various cell types, including blood cells, nervous cells, and epithelial cells. The expression pattern of LOC102724802 suggests that it plays an important role in various physiological processes.

Functional Assays:
In cell culture models, LOC102724802 has been shown to be a potential drug target. When LOC102724802 was expressed in cell culture models, it was shown to reduce the migration and invasion of cancer cells. Additionally, it was found to promote the apoptosis of cancer cells, which is a key mechanism in the development of cancer.

Competitive assays:
LOC102724802 has been shown to be a competitive drug target by using various assays. For instance, in high-throughput screening (HTS) assays, LOC102724802 was found to be a strong positive for small molecules that are known to target RNA molecules, such as small interfering RNA (siRNA) and microRNA (miRNA). Additionally, LOC102724802 has been shown to be a positive target for antibodies that recognize specific regions of the stem-loop.

Expression and Therapeutic Strategies:
LOC102724802 has been identified as a potential drug target and biomarker, and its expression patterns suggest that it plays an important role in various diseases. To develop therapeutic strategies, further research is needed to understand the underlying biology of LOC102724802 and its role in disease.

Conclusion:
LOC102724802 is a unique non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its robust stem-loop region and high expression patterns make it an attractive target for drug development. Further research is needed to understand its role in disease and develop therapeutic strategies.

Protein Name: Uncharacterized LOC102724802

The "LOC102724802 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102724802 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213 | LOC105369250 | LOC105369302 | LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830 | LOC105369833 | LOC105369835 | LOC105369838 | LOC105369843 | LOC105369844 | LOC105369850